Back to Archived Journals » Vaccine: Development and Therapy

Vaccine: Development and Therapy ceased publishing in November 2016. All new submissions can be made to Drug Design, Development and Therapy乐动体育西班牙人. All articles that have been published in Vaccine: Development and Therapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Vaccine: Development and Therapy


        

Journal Articles:

乐动体育西班牙人- 31 records -

The new first-line defense: the potential of nasopharyngeal colonization in vaccine strategies

Chan WY, Cohen JM, Brown JS

Vaccine: Development and Therapy 2016乐动体育西班牙人, 6:47-57

Published Date: 17 October 2016

Management of visceral leishmaniasis with therapeutic vaccines

Rawat K, Yadav NK, Joshi S, Ratnapriya S, Sahasrabuddhe AA, Dube A

Vaccine: Development and Therapy 2016, 6:33-45

Published Date: 28 September 2016

RTS,S malaria vaccine development: progress and considerations for postapproval introduction

乐动体育西班牙人Asante KP, Adjei G, Enuameh Y, Owusu-Agyei S

Vaccine: Development and Therapy 2016乐动体育西班牙人, 6:25-32

Published Date: 20 June 2016

Tularemia vaccine development: paralysis or progress?

Sunagar R, Kumar S, Franz BJ, Gosselin EJ

Vaccine: Development and Therapy 2016, 6:9-23

Published Date: 4 May 2016

Hendra and Nipah viruses: pathogenesis, animal models and recent breakthroughs in vaccination

Weingartl HM

Vaccine: Development and Therapy 2015乐动体育西班牙人, 5:59-74

Published Date: 28 September 2015

Development of a vaccine for Chlamydia trachomatis: challenges and current progress

乐动体育西班牙人Hafner LM, Timms P

Vaccine: Development and Therapy 2015, 5:45-58

Published Date: 17 August 2015

Current and future prophylactic vaccines for hepatitis C virus

乐动体育西班牙人Dunlop JI, Owsianka AM, Cowton VM, Patel AH

Vaccine: Development and Therapy 2015乐动体育西班牙人, 5:31-44

Published Date: 11 August 2015

Immunosenescence: implications for vaccination programs in the elderly

乐动体育西班牙人Loukov D, Naidoo A, Bowdish DME

Vaccine: Development and Therapy 2015乐动体育西班牙人, 5:17-29

Published Date: 6 August 2015

A database in ACCESS for assessing vaccine serious adverse events

Thomas RE, Jackson D

Vaccine: Development and Therapy 2015, 5:9-16

Published Date: 20 April 2015

Vaccines for metabolic diseases: current perspectives

乐动体育西班牙人Morais T, Andrade S, Pereira SS, Monteiro MP

Vaccine: Development and Therapy 2014乐动体育西班牙人, 4:55-72

Published Date: 2 September 2014

Challenges to developing effective streptococcal vaccines to prevent rheumatic fever and rheumatic heart disease

Sharma A, Nitsche-Schmitz DP

Vaccine: Development and Therapy 2014乐动体育西班牙人, 4:39-54

Published Date: 2 May 2014

Current progress toward vaccines against Toxoplasma gondii

Garcia JL, Innes EA, Katzer F

Vaccine: Development and Therapy 2014乐动体育西班牙人, 4:23-37

Published Date: 16 April 2014

Changing epidemiology of hepatitis A virus in Indian children

乐动体育西班牙人Arankalle V, Mitra M, Bhave S, Ghosh A, Balasubramanian S, Chatterjee S, Choudhury J, Chitkara A, Kadhe G, Mane A, Roy S

Vaccine: Development and Therapy 2014, 4:7-13

Published Date: 18 January 2014

Immunogenicity and safety of live attenuated hepatitis A vaccine (Biovac-A™) in healthy Indian children

Bhave S, Ghosh A, Sapru A, Mitra M, Chatterjee S, Bhattacharya N, Kadhe G, Mane A, Roy S

Vaccine: Development and Therapy 2014, 4:1-6

Published Date: 19 December 2013

Melanoma vaccines: trials and tribulations

Dillman RO

Vaccine: Development and Therapy 2013, 3:57-78

Published Date: 10 October 2013

Current research and clinical trials for a vaccine against Chikungunya virus

乐动体育西班牙人Singh P, Chhabra M, Mittal V, Sharma P, Rizvi MA, Chauhan LS, Rai A

Vaccine: Development and Therapy 2013, 3:35-46

Published Date: 9 August 2013

Forced degradation studies: an essential tool for the formulation development of vaccines

Hasija M, Li L, Rahman N, Ausar SF

Vaccine: Development and Therapy 2013, 3:11-33

Published Date: 13 June 2013

Key feasibility considerations when conducting vaccine clinical trials in Asia–Pacific countries

乐动体育西班牙人Lansang EZ, Tan K, Nayak S, Lee KJ, Wai K

Vaccine: Development and Therapy 2013, 3:1-9

Published Date: 19 March 2013

Cytolethal distending toxin as virulence factor, protective antigen, and target for vaccine development

Lagergård T, Keith J

Vaccine: Development and Therapy 2012乐动体育西班牙人, 2:51-60

Published Date: 6 December 2012

Assessment of chicken protection against Campylobacter jejuni infection by immunization with avirulent Salmonella enterica sv. Typhimurium strain producing Campylobacter CjaD/Pal protein

乐动体育西班牙人Łaniewski P, Lis M, Wyszyńska A, Majewski P, Godlewska R, Jagusztyn-Krynicka EK

Vaccine: Development and Therapy 2012乐动体育西班牙人, 2:43-50

Published Date: 31 August 2012

Realizing the promise of breast cancer vaccines

乐动体育西班牙人Jackson E, Soliman H

Vaccine: Development and Therapy 2012, 2:35-41

Published Date: 22 August 2012

Reasons for not having received influenza vaccination and its predictors in Canadians

Chen Y, Wu J, Yi QL, Laroche J, Wong T

Vaccine: Development and Therapy 2012, 2:23-33

Published Date: 13 August 2012

Advances in the development of vaccines for dengue fever

Simmons M, Teneza-Mora N, Putnak R

Vaccine: Development and Therapy 2012, 2:1-14

Published Date: 4 May 2012

A new forum to spread the word on vaccine research

Pasetti MF

Vaccine: Development and Therapy 2011, 1:1-2

Published Date: 2 May 2011